Botulinum Toxin
From aesthetic medicine to medical applications.
Botulinum toxin is one of the most extensively studied treatments used in modern aesthetic and medical practice. Although it is widely associated with the treatment of facial lines and wrinkles, its medical applications extend far beyond aesthetics. It works by temporarily reducing the release of acetylcholine at the neuromuscular junction, reducing excessive muscle activity in targeted areas. Botulinum toxin is a prescription-only medicine in the UK, meaning treatment should only be provided following an appropriate assessment and prescription by an authorised prescriber.
Treatment focus
More than an aesthetic treatment
Depending on the specific formulation and its UK licence, botulinum toxin may be used in the management of conditions including chronic migraine, severe primary axillary hyperhidrosis that has not responded adequately to topical treatment, certain muscle spasms and neurological disorders, and specific bladder disorders. These treatments follow specific medical protocols and are distinct from aesthetic applications.
In aesthetic medicine
In aesthetic medicine, botulinum toxin can be used to temporarily reduce the appearance of dynamic facial lines — lines that develop as a result of repeated muscle contraction, such as forehead lines, glabellar lines between the eyebrows and lateral canthal lines around the eyes. The aim of treatment is not to eliminate facial movement completely; a well-planned treatment takes into account the individual’s facial anatomy, muscle activity and desired outcome.
Not all products are the same
There are several authorised botulinum toxin formulations, and they are not simply interchangeable versions of the same medicine. They may vary in manufacturing processes, molecular characteristics, excipients, storage requirements and licensed indications. Importantly, units are not interchangeable between different products: each formulation has its own dosing guidance and must be prescribed and administered according to its product-specific information.
Type A and Type B
Botulinum toxins belong to different serotypes, including Type A and Type B. Most aesthetic applications use Type A formulations. Type B has different pharmacological characteristics and is used in specific medical circumstances — it is not simply a stronger or better version of Type A. The choice of product depends on the clinical indication, patient history, regulatory status and professional judgement.
Can someone become resistant?
Reduced response can occur, although true immunological resistance is considered uncommon. Neutralising antibodies can develop in some circumstances and may reduce effectiveness. However, a reduced or shorter-lasting response does not automatically mean resistance has developed: treatment technique, dose, muscle anatomy, treatment intervals, individual response, changes in the targeted muscles and product-specific characteristics can all contribute. A patient experiencing a reduced response should undergo an appropriate clinical assessment before assuming resistance.
Choosing a safe and regulated treatment
Because botulinum toxin is a prescription-only medicine, it is important that patients receive treatment from an appropriately qualified practitioner using an authorised product obtained through a regulated supply chain. The MHRA has issued warnings about unlicensed and counterfeit botulinum toxin products, highlighting the importance of checking that the product being used is authorised for use in the UK.
Why medical assessment matters
Botulinum toxin is not a one-size-fits-all treatment. Before any prescription-only treatment is considered, your clinician should assess your medical history, current medications, previous treatments, facial anatomy and muscle activity where relevant, the condition or concern being treated, your individual goals, and potential contraindications and risks. The specific treatment, product, dose and injection sites should only be determined following an appropriate clinical assessment.
At Sol Clinic, we believe that aesthetic medicine should begin with medical assessment, not simply a request for a particular product. Every face is different, and every patient has different anatomy, muscle activity, medical history and expectations.
For this reason, prescription-only treatments are considered only after an appropriate consultation, where your clinician can determine whether treatment is medically suitable and discuss the available options with you.
Treatment investment
Prescription-only medicines are supplied only where clinically appropriate following consultation and assessment. Treatment options and costs are discussed with you at your medical consultation.
Book a private consultationBook a Private Consultation
Every treatment begins with a consultation and a detailed assessment. Speak with our team to arrange yours, handled with discretion.
